Image

IgNS

Advancing Ig Therapy Practice

EmailEmailLinkedInLinkedInFacebookFacebookInstagramInstagramXX
Patient Guide to Immunoglobulin Therapy
Patient Guide to Immunoglobulin Therapy
IgNS Website
IgNS Website

Patient 360 Virtual Conference

Add to Your Calendar: 2026 Patient 360 Virtual Conference
Patient 360 Conference Prospectus

IgNS National Conference

IgNS 2026 Call for Topics & Speakers
IgNS 2026 Call for Topics & Speakers
Access IgNS 2025 On-Demand CE/CME Evaluations
IgNS 2025 14th National Conference On-Demand
IgNS 2026 Prospectus
IgNS 2026 Sponsor & Exhibitor Interest Form

Features in Publications

Recombinant Human Hyaluronidase PH20 in Biologics and Immunoglobulin Therapy: Clinical Applications
Recombinant Human Hyaluronidase PH20 in Biologics and Immunoglobulin Therapy: Clinical Applications
2025 Specialty Pharmacy Continuum Special Edition
2025 Specialty Pharmacy Continuum Special Edition
Fundamentals of Subcutaneous Immunoglobulin Therapy
Fundamentals of Subcutaneous Immunoglobulin Therapy
Immunoglobulin Therapy Aseptic Meningitis Syndrome
Immunoglobulin Therapy Aseptic Meningitis Syndrome
Immunologic and Anaphylactoid Reactions in Ig Therapy
Immunologic and Anaphylactoid Reactions in Ig Therapy

Patients

Patient Experience Survey
Patient Experience Survey

IgCN®/IgCP® Certifications

Register for an IgCN®/IgCP® Exam
Register for an IgCN®/IgCP® Exam
View All IgCN®/IgCP® Certification Exam Windows

IgNS Resources

Image
Ig Therapy Standards of Practice (Version 3.2)
Image
IgNS Product & Risk Factors Chart

IgNS Features

CE/CME Webinar Programs
IgNS on SamaCare’s The Road to Care Podcast: Advancing Standards in Ig Therapy
Press Release: IgNS Appoints Amy E. Clarke, DNP, RN, IgCN®, as Chief Clinical Officer
Press Release: IgNS Appoints Amy E. Clarke, DNP, RN, IgCN®, as Chief Clinical Officer
Communications Medicine Article | Large-scale deep learning analysis to identify adult patients at risk for combined and common variable immunodeficiencies
Communications Medicine Article | Large-scale deep learning analysis to identify adult patients at risk for combined and common variable immunodeficiencies

View on mobile